(Q34257909)

31 July 2017

1 reference

title

Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients (English)

1 reference

31 July 2017

1 reference

P E Wallemacq

1

1 reference

31 July 2017

R K Verbeeck

series ordinal

2

1 reference

31 July 2017

publication date

1 January 2001

1 reference

Clinical Pharmacokinetics

31 July 2017

published in

1 reference

31 July 2017

volume

40

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

283-295

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200140040-00004

31 July 2017

exact match

0 references

cites work

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

1 reference

12 December 2020

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

1 reference

12 December 2020

FK 506 inhibition of cyclosporine metabolism by human liver microsomes

1 reference

12 December 2020

Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood

1 reference

12 December 2020

Comparison of old and new IMX assays for monitoring of tacrolimus levels

1 reference

12 December 2020

FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

1 reference

12 December 2020

Plasma protein binding of tacrolimus in humans

1 reference

12 December 2020

Interactions between FK506 and rifampicin or erythromycin in pediatric liver recipients

1 reference

12 December 2020

Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay

1 reference

12 December 2020

Diltiazem increases tacrolimus concentrations

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations

1 reference

12 December 2020

Dosing of MMF in combination with tacrolimus for steroid-resistant vascular rejection in pediatric renal allografts.

1 reference

12 December 2020

Monitoring FK 506 concentrations in plasma and whole blood

1 reference

12 December 2020

HPLC-microparticle enzyme immunoassay specific for tacrolimus in whole blood of hepatic and renal transplant patients

1 reference

12 December 2020

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

1 reference

12 December 2020

Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients

1 reference

12 December 2020

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

1 reference

12 December 2020

A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

1 reference

12 December 2020

Stability of FK506 in blood samples

1 reference

12 December 2020

Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants

1 reference

12 December 2020

A combined HPLC-ELISA evaluation of FK 506 in transplant patients

1 reference

12 December 2020

Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation

1 reference

12 December 2020

Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus

1 reference

12 December 2020

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

1 reference

12 December 2020

A whole blood FK 506 assay for the IMx analyzer

1 reference

12 December 2020

Interaction between FK506 and clotrimazole in a liver transplant recipient

1 reference

12 December 2020

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

1 reference

12 December 2020

FK 506: monitoring in plasma or in whole blood?

1 reference

12 December 2020

Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients

1 reference

12 December 2020

Improvement and assessment of enzyme-linked immunosorbent assay to detect low FK506 concentrations in plasma or whole blood within 6 hours

1 reference

12 December 2020

Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection

1 reference

12 December 2020

Interaction between FK 506 and clarithromycin in a renal transplant patient

1 reference

12 December 2020

FK 506 interaction with danazol

1 reference

12 December 2020

A highly sensitive method to assay FK-506 levels in plasma

1 reference

12 December 2020

Nifedipine interaction with tacrolimus in liver transplant recipients

1 reference

12 December 2020

Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506

1 reference

12 December 2020

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

12 December 2020

Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat

1 reference

12 December 2020

Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children

1 reference

12 December 2020

Clinical use of tacrolimus (FK-506) in infants and children with renal transplants

1 reference

12 December 2020

HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes

1 reference

12 December 2020

Improved procedures for enzyme immunoassay of tacrolimus (FK506) in whole blood

1 reference

12 December 2020

FK506 measurement: comparison of different analytical methods

1 reference

12 December 2020

Clinical pharmacokinetics of tacrolimus

1 reference

12 December 2020

Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus

1 reference

12 December 2020

FK 506/fluconazole interaction enhances FK 506 nephrotoxicity

1 reference

12 December 2020

In-vitro interaction of a novel immunosuppressant, FK 506, and antacids

1 reference

12 December 2020

A simplified whole blood enzyme-linked immunosorbent assay (ProTrac II) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents

1 reference

12 December 2020

Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes

1 reference

12 December 2020

Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat

1 reference

12 December 2020

P-glycoprotein and drug therapy in organ transplantation

1 reference

12 December 2020

Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients

1 reference

12 December 2020

Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation

1 reference

12 December 2020

Interaction between tacrolimus and erythromycin

1 reference

12 December 2020

Clinically significant drug interactions with new immunosuppressive agents

1 reference

12 December 2020

Interaction between tacrolimus and chloramphenicol in a renal transplant recipient.

1 reference

12 December 2020

Compassionate use of FK 506 in pediatric liver transplantation: a pilot study

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

The use of tacrolimus in pediatric liver transplantation

1 reference

12 December 2020

Effect of temperature and hematocrit on plasma concentration of FK 506

1 reference

12 December 2020

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

1 reference

12 December 2020

Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers

1 reference

12 December 2020

FK506 and pregnancy in liver transplant patients

1 reference

12 December 2020

IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients

1 reference

12 December 2020

Therapeutic drug monitoring of tacrolimus in clinical transplantation.

1 reference

12 December 2020

A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry

1 reference

12 December 2020

The role of tacrolimus in adult kidney transplantation: a review

1 reference

12 December 2020

Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection

1 reference

12 December 2020

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

12 December 2020

Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients

1 reference

12 December 2020

Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies

1 reference

12 December 2020

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

1 reference

12 December 2020

Fluconazole therapy in transplant recipients receiving FK506.

1 reference

12 December 2020

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

1 reference

12 December 2020

FK 506 assay past and present--characteristics of FK 506 ELISA

1 reference

12 December 2020

Cytochrome P450 3A: ontogeny and drug disposition

1 reference

12 December 2020

Pharmacokinetics of FK 506 in transplant patients

1 reference

12 December 2020

Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients

1 reference

12 December 2020

Pharmacokinetics of FK506 after intravenous and oral administration in patients awaiting renal transplantation

1 reference

12 December 2020

Stability of FK 506 in whole blood samples

1 reference

12 December 2020

Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).

1 reference

12 December 2020

Pediatric intravenous FK506--how much are we really infusing?

1 reference

12 December 2020

The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects

1 reference

12 December 2020

Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry

1 reference

12 December 2020

High performance liquid chromatography/mass spectrometry of FK 506 and its metabolites in blood, bile, and urine of liver grafted patients

1 reference

12 December 2020

Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation

1 reference

12 December 2020

Orthotopic liver transplantation in dogs receiving FK-506.

1 reference

12 December 2020

Consensus document: therapeutic monitoring of tacrolimus (FK-506).

1 reference

12 December 2020

Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group

1 reference

12 December 2020

Pharmacokinetics of tacrolimus in liver transplant patients.

1 reference

12 December 2020

10.2165/00003088-200140040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1002626824

0 references

1 reference